FDA should reign in counterfeit drugs
It is time for the U.S. Food and Drug Administration to exercise its authority and reign in the unregulated manufacturing of GLP-1 drugs, which are more commonly known as weight loss drugs. As demand for name brand GLP-1 weight-loss medications like Mounjaro, Zepbound, Ozempic and Wegovy drugs has risen, an unregulated manufacturing market has developed. Counterfeit GLP-1 drugs have become widely accessible. These counterfeit versions are not subject to FDA regulations. Even more unsettling are the reports that counterfeit versions of these drugs have been their way into the U.S. ...